Skip to content
    Real-World Studies

    LDCT Lung Cancer Screening Uptake and Predictors in Occupationally Asbestos-Exposed Workers

    Oubaid et alBMC pulmonary medicine

    LDCT Lung Cancer Screening Uptake and Predictors in Occupationally Asbestos-Exposed Workers
    In Germany, lung cancer remains frequently diagnosed at advanced stages. To facilitate early detection, the German Social Accident Insurance (DGUV) provides lung cancer screening with low-dose computed tomography (LDCT) for individuals with confirmed occupational asbestos dust exposure and a smoking history of at least 30 pack-years.
    A cross-sectional secondary analysis evaluated administrative and routine medical data collected between 2014 and 2024 to determine factors influencing screening adherence following medical consultation. The study cohort comprised 14,491 individuals who were predominantly male (97%), with an average age of 67 years, a mean duration of asbestos dust exposure of 21 years, and an average smoking history of 43 pack-years.
    Overall, 74% of counseled individuals proceeded to undergo LDCT screening. In an exploratory multivariable logistic regression evaluating 13 potential variables, independent predictors associated with higher screening uptake included younger age (OR: 0.96, p < 0.001), longer cumulative exposure to asbestos dust (OR: 1.01, p = 0.011), and a documented history of pneumonia (OR: 1.16, p = 0.011). However, the model demonstrated limited explanatory capacity (Nagelkerke's R² = 0.026), indicating that routine clinical and administrative parameters alone do not account for the majority of variance driving patient participation decisions.

    Key Takeaways

    • Following medical consultation, 74% of high-risk individuals with occupational asbestos exposure and substantial smoking history underwent LDCT lung cancer screening (n = 14,491).
    • Screening uptake was significantly associated with younger age (OR: 0.96, p < 0.001), longer duration of asbestos dust exposure (OR: 1.01, p = 0.011), and a medical history of pneumonia (OR: 1.16, p = 0.011), though overall explanatory variance remained low (Nagelkerke's R² = 0.026).
    Read the original sourceBMC pulmonary medicine